the current state of the art in hr-mds and the need to improve treatment approaches
Published 2 years ago • 47 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:04
state-of-the-art treatment for hr-mds
-
2:16
current and future treatment approaches for hr-mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:19
the current state-of-the-art in pv and future outlooks
-
6:49
watch the process: sometimes journal page
-
6:11
watch the process - find good art journal page
-
1:00:41
automotive radar – an overview on state-of-the-art technology
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
7:05
state-of-the-art treatment regimens for lr-mds
-
1:34:34
declaration of helsinki doh revision process
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:04
the future of mds management
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
7:10
the current state of the art in r/r multiple myeloma: a european perspective
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:41
an overview of the latest advances in hematology
-
2:50
state of the art in car-t
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics